Predictive Multimodal MRI Factors in Subacute Cerebral Artery Occlusiontreated by Thrombectomy (PIMISUTT)
Recruiting
N/A
Interventional Study
Middle Cerebral Artery Acute Ischemic Stroke
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 50 (estimated)
- Sponsor
- Poitiers University Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Our study aims to measure metabolic and functional parameters of the infarcted territory by multimodal cerebral MRI in patients diagnosed with unilateral proximal occlusion of the middle cerebral artery and treated by thrombectomy in order to correlate those parameters to clinical outcome (evaluated by modified Rankin score) at 3 months.
We aim to find early radiologic predictive factors for favo…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients aged ≥ 18 years old
* Hospitalized at the Poitiers University Hospital
* Acute middle cerebral artery occlusion diagnosed by CT-scan or MRI
* NIHSS score ≥ 6 at admission
* To be treated by thrombectomy with or without fibrinolysis
* Written information delivered to t…
Contacts